Cargando…
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis
Background: Severe acute respiratory syndrome coronavirus 2 disease (COVID-19) has caused a worldwide challenging and threatening pandemic. Multinational, placebo-controlled, observer-blinded trials were conducted since the beginning of pandemic because safe and effective vaccines were needed urgent...
Autores principales: | Nuzzo, Amedeo, Manacorda, Simona, Sammarco, Enrico, Sbrana, Andrea, Bazzurri, Serena, Paolieri, Federico, Manfredi, Fiorella, Mercinelli, Chiara, Ferrari, Marco, Massaro, Giulia, Bonato, Adele, Salfi, Alessia, Galli, Luca, Morganti, Riccardo, Antonuzzo, Andrea, Cremolini, Chiara, Masi, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227366/ https://www.ncbi.nlm.nih.gov/pubmed/35746500 http://dx.doi.org/10.3390/vaccines10060892 |
Ejemplares similares
-
Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions
por: Sammarco, Enrico, et al.
Publicado: (2023) -
1711P SARS-CoV-2 infection in prostate cancer patients: Data from a high-incidence area in Italy
por: Sbrana, A., et al.
Publicado: (2020) -
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
por: Caruso, Teresita, et al.
Publicado: (2023) -
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
por: Caruso, Teresita, et al.
Publicado: (2023) -
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study
por: Marconcini, Riccardo, et al.
Publicado: (2022)